News 2012

Article on the NightBalance Sleep Position Trainer (Dutch)

Date: 15/12/2012

15 December 2012, Delft, The Netherlands – The journal “Tijdschrift voor Ergonomie” has published a full article on the innovative Sleep Position Trainer (more…)

arGEN-X announces grant of broad US patent covering its SIMPLE Antibody™ platform

Date: 06/12/2012

6 December 2012, Breda, the Netherlands, and Ghent, Belgium – arGEN-X has received its first Notice of Allowance from the United States Patent and Trademark Office (USPTO) in connection with a portfolio of patent filings related to its SIMPLE Antibody™ discovery platform. (more…)

Fabpulous launches new company website

Date: 22/11/2012

21 November 2012, Maastricht – Fabpulous has today launched its new website. The new site highlights both the innovative ultra-rapid plasma preparation technology as well as Fabpulous’ first product, (more…)

Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering

Date: 06/11/2012

6 November 2012, Watertown, Mass., USA – Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious (more…)

Cristal Delivery wins prize “Utrechtse Ster 2012”

Date: 31/10/2012

31 October 2012, Utrecht, The Netherlands – Cristal Delivery announced today that it has won the prize “Utrechtse Ster 2012″‘. The announcement (more…)

ARGEN-X Appoints Dr. David Lacey to its Supervisory Board

Date: 25/10/2012

25 October 2012 , Breda, the Netherlands and Ghent, Belgium – arGEN-X has strengthened its supervisory board with the appointment of Dr. David L. Lacey. (more…)

Enanta’s lead hepatitis C compound ABT-450 advances into clinical phase 3 through its collaboration with Abbott

Date: 18/10/2012

October 17, 2012, Watertown MA, USA – Enanta Pharmaceuticals, Inc., announced that Abbott initiated an interferon-free combination Phase 3 clinical trial for hepatitis C (more…)

DCPrime appoints Marcel Zwaal EO, and Dr. Anthony Hall CMO and expands Supervisory Board

Date: 09/10/2012

9 October 2012, Leiden, The Netherlands – Cancer vaccine company DCPrime today announced the appointments of Marcel Zwaal as Chief Executive Officer, and of Dr. Anthony Hall as Chief Medical Officer. (more…)

RuiYi and arGEN-X announce license agreement for ARGX-109

Date: 04/10/2012

October 4, 2012, Gent, Belgium – RuiYi (formerly Anaphore) and arGEN-X BV announced today that arGEN-X has granted a worldwide exclusive license to RuiYi to develop and commercialize ARGX-109 (more…)

Gaia magazine features Okapi as example company (Dutch)

Date: 21/09/2012

20 September 2012, Leuven, Belgium – The Belgium animal rights organization Gaia (Global Action in the Interest of Animals) features Okapi Sciences (more…)

FierceBiotech names Enanta a fierce 15 winner

Date: 20/09/2012

19 September 2012 – Watertown, Mass., USA – Enanta Pharmaceuticals, Inc. announced today that it was named by FierceBiotech as one of 2012’s Fierce 15. (more…)

First clinical paper published for Sleep Position Trainer

Date: 03/09/2012

3 September 2012, Delft – A first clinical paper has been published demonstrating clinical efficacy of the Sleep Position Trainer of NightBalance. (more…)

Doorslapen met triller of implantaat ‘Aardverschuiving’ in strijd tegen apneu

Date: 29/08/2012

29 August 2012, Delft – The quality newspaper “De Volkskrant” today published a positive paper on NightBalance’s Sleep Position Trainer device (more…)

DCPrime appears in review of BioCentury Weekly magazine

Date: 18/06/2012

18 June 2012, Amsterdam – In its weekly issue, BioCentury has published a review on cancer immunotherapy, mentioning DCPrime (more…)

Thuja Capital invests in Utrecht University spin-off Cristal Delivery

Date: 18/06/2012

18 June 2012, Utrecht – Thuja Capital announced today that on Friday June 15 it has closed an investment in Cristal Delivery (more…)

Okapi Sciences enters into distribution agreement with MegaCor Diagnostik

Date: 14/06/2012

14 June 2012, Leuven, Belgium – Okapi Biosciences has entered into a distribution agreement with into a distribution agreement for its diagnostic kit for rapid koi herpesvirus (KHV) detection with MegaCor Diagnostik GmbH. (more…)

Article on Okapi Sciences in Trends (Dutch)

Date: 14/06/2012

14 June 2012, Leuven, Belgium – The Belgian weekly magazine Trends published an article on Okapi Sciences, which can be found and read here (Dutch language)

Financieele Dagblad publishes article on Cristal Delivery (Dutch)

Date: 31/05/2012

Utrecht, The Netherlands, 31 May 2012  – The Dutch financial newspaper Financieele Dagblad today published an extensive article on Cristal Delivery (more…)

DCPrime interview in Management Team magazine (Dutch)

Date: 10/05/2012

Amsterdam, The Netherlands, 10 May 2012 – The Dutch management magazine Management Team (No 611) has published an article on DCPrime (more…)

NightBalance in Quote Magazine (Dutch)

Date: 04/04/2012

Delft, The Netherlands, April 2012 – The Dutch magazine Quote published an article on NightBalance and its founders. Find the article here.

Akeso Medical Imaging starts clinical POC study in RA

Date: 02/03/2012

Eindhoven, The Netherlands, March 2, 2012 – Akeso Medical Imaging announced the start of a clinical study with their novel imaging device (more…)

Galapagos and Abbott announces global collaboration

Date: 29/02/2012

Mechelen, Belgium, 29 February 2012 – Abbott and Galapagos announced today that they have entered into a global collaboration (more…)

arGEN-X enters into therapeutic antibody alliance with Shire

Date: 29/02/2012

Rotterdam/Ghent, February 29, 2012 – arGEN-X announced that it has entered into an alliance with Shire to create (more…)

NightBalance launches the Sleep Position Trainer to treat positional apnea

Date: 27/02/2012

Delft, 27 February 2012 – NightBalance launches its first innovative product in the Netherlands: the Sleep Position Trainer. (more…)

Enanta enters into strategic collaboration to advance NS5A inhibitor candidate for HCV

Date: 21/02/2012

Watertown, Mass., USA, February 21, 2012 – Enanta Pharmaceuticals Inc. announced today that it has entered into an exclusive collaboration and license agreement with Novartis (more…)

DCPrime obtains EMA Orphan Medicinal Product approval for AML vaccine

Date: 01/02/2012

Amsterdam, The Netherlands – DCPrime today announced that the Committee for Orphan Medical Products (COMP) of the European Medicines Agency has issued a positive opinion (more…)